Trial Condition(s):
Study on safety, tolerability and pharmacokinetics of one tablet Adalat OROS 30 or of one tablet Nifedipine Sandoz retard 30 after an overnight fasting or immediately after an American breakfast in healthy male volunteers
Please see attached Study Results Summary below
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | Status | ||
---|---|---|---|
Locations SocraTec R&D Clinical Ward Erfurt, Germany, 99084 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |